Gene therapy has emerged as a promising approach to previously untreatable conditions, including Duchenne muscular dystrophy (DMD), a progressive disorder caused by DMD mutations that leads to early ...

The FDA has granted marketing authorization to CT-132 for the preventive treatment of episodic migraine in patients aged 18 years and older.

The global cannabis use disorder treatment market is poised for strong growth, driven by rising cannabis consumption, the legalisation of cannabis for recreational and medicinal use, and increasing ...